Influence factors of metronidazole-related CNS disorders: an analysis of the Japan adverse drug event report and FDA adverse event reporting system

<p>Metronidazole (MNZ) can be administered for various infections. The impact of comorbidities/concomitant drugs on MNZ-induced central nervous system (CNS) disorders remains unclear.</p> <p>We assessed the risk of metronidazole-related CNS disorders using the Japan Adverse Drug Ev...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Keisuke Takada (20871224) (author)
مؤلفون آخرون:	Yuki Enoki (757318) (author), Masaru Samura (20871227) (author), Yuki Igarashi (4997979) (author), Kazuaki Taguchi (567863) (author), Koji Tanikawa (20871242) (author), Kazuaki Matsumoto (2120611) (author)
منشور في:	2025
الموضوعات:	Biophysics Biochemistry Medicine Cell Biology Genetics Molecular Biology Neuroscience Physiology Pharmacology Biotechnology Immunology Cancer Science Policy Mental Health Chemical Sciences not elsewhere classified Central nervous system disorders clonazepam Japanese adverse drug event report metronidazole US food and drug administration adverse event reporting system
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Influence factors of metronidazole-related CNS disorders: an analysis of the Japan adverse drug event report and FDA adverse event reporting system

مواد مشابهة